Press ReleaseView printer-friendly version << Back
New Survey Identifies Opportunity to Improve Shared Decision Making Between Cardiologists and Heart Valve Disease Patients
More than five million Americans are currently impacted by heart valve disease, and 1.5 million have one of the most common forms, aortic stenosis (AS). Currently, treatment options for AS include transcatheter aortic valve replacement (TAVR), a minimally invasive procedure, or a surgical aortic valve replacement (SAVR), also known as open heart surgery. However, more than half of cardiologists surveyed (53%) feel that their symptomatic severe AS patients are not as informed as they should be about their treatment options.
The findings indicate physicians recognize the importance of shared decision making to achieve individualized care for heart valve disease patients. This reinforces new ACC/AHA Heart Valve Disease Guidelines released in
"In light of new guidelines, it is more important than ever to understand how to actually achieve shared decision-making goals in clinical practice,"
The survey drew parallels to the recent Active Living survey by patient advocacy group Heart-Valve-Surgery.com of more than 3,400 patients and caregivers, showing that both physicians and patients want to improve the doctor/patient dialogue to help create more individualized treatment plans which can lead to improved outcomes.
In fact, nearly 75% of cardiologists surveyed who regularly treat AS patients said they discuss treatment options with their patients at the time of the diagnosis (CardioSurve). Similarly, the Active Living patient survey found that doctor/patient dialogue was the highest reported factor in determining treatment decisions. More than 90% of respondents who identified as a heart valve patient said that they are influenced by conversations with their doctors (Active Living). Yet, more than one-third of patients (37.4%) wished they asked more questions at their doctor's appointment during their heart valve disease treatment journey (Active Living).
"We know patients with AS count on discussions with their cardiologists, making it even more important to fine-tune how they prepare for these critical decisions," said Adam Pick, patient advocate and founder of Heart-Valve-Surgery.com. "As an advocate for heart valve disease education, I hope these insights empower patients to find their voice and know that their physicians value the dialogue around their treatment goals and preferences."
The CardioSurve results also suggests key factors driving treatment choices and the preparation for conversations can vary between physicians and patients:
- The top three items that cardiologists believe would better prepare their patients prior to their discussion include:
- Having a family member/friend attend the visit to take notes and ask follow-up questions (59%)
- Use of a patient decision aid (53%)
- Come with a list of questions to ask during the appointment (46%)
- The most important factor to physicians when determining the best treatment option for patients is the risk of mortality (70% - CardioSurve), while nearly half of patients (49% - Active Living) cite a return to an active lifestyle as a key factor in their treatment decision.
"As a global leader in heart valve innovation, Medtronic is committed to advancing our structural heart therapies to standard of care and expanding access to patients around the world," said
ABOUT THE SURVEYS
This research was designed to develop a general understanding from
These results are based on an online survey issued to the Heart-Valve-Surgery.com community in
View original content to download multimedia:http://www.prnewswire.com/news-releases/new-survey-identifies-opportunity-to-improve-shared-decision-making-between-cardiologists-and-heart-valve-disease-patients-301291465.html